Y-mAbs Therapeutics Inc (NASDAQ:YMAB)
| 6.17 Delayed Data As of Dec 01 |  -0.045 / -0.72%Today’s Change | 2.70 Today|||52-Week Range 10.95 | +26.33% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2016 | 2017 | 2018 | -- | |||
| Revenue and Income | Net Revenues | 0.00 | 0.00 | 0.00 | -- | -- |
| Depreciation And Amortization | 0.00 | 0.00 | 29.0K | -- | ||
| Operating Expenses | Gross Income | 0.00 | 0.00 | -29.0K | -- | |
| General Expenses | 17.0M | 19.2M | 43.2M | -- | ||
| Research And Development | 13.9M | 14.3M | 34.3M | -- | ||
| Total Operating Expenses | 17.0M | 19.2M | 43.2M | -- | ||
| Non-Operating Expenses | Operating Income | -17.0M | -19.2M | -43.2M | -- | |
| Other Expenses | -18.0K | 83.0K | -44.0K | -- | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -17.1M | -19.2M | -43.3M | -- | |
| Net Income | -17.1M | -19.2M | -43.3M | -- | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 34.2M | 34.2M | 28.8M | -- | |
| Shares To Calculate EPS Diluted | 34.2M | 34.2M | 28.8M | -- | ||
| Earnings Per Share | EPS | -$0.50 | -$0.56 | -$1.50 | -- | |
| EPS Diluted | -$0.50 | -$0.56 | -$1.50 | -- | ||
